My Size, Inc. filings document the public-company reporting record for a Nasdaq-listed fashion technology and commerce issuer. The company’s Form 8-K filings report operating results, preliminary financial information, Regulation FD communications, shareholder letters and Nasdaq listing-compliance notices related to its common stock.
Proxy and annual-meeting filings cover board elections, equity incentive plan amendments, share-reserve provisions, auditor ratification and stockholder voting results. The filing record also includes late-filing notices for periodic reports, together with exhibits and Inline XBRL cover-page data that support the company’s formal disclosure of results, governance matters, capital structure and reporting status.
My Size, Inc. reported strong top-line growth but significantly higher losses for the six months ended June 30, 2026. Revenue rose to $5.46 million from $3.49 million, driven mainly by its fashion e-commerce platform and consolidation of ShoeSizeMe and Ten Peacks, with Q2 revenue up to $3.07 million from $2.01 million.
Operating expenses increased across research and development, sales and marketing, and general and administrative, lifting operating loss to $3.13 million from $1.65 million and widening net loss to $3.23 million from $1.51 million. Cash, cash equivalents and restricted cash declined to $0.71 million at June 30, 2026, and management states there is substantial doubt about the company’s ability to continue as a going concern without additional capital. The company has an ATM program and a new $10.0 million equity purchase facility, but also highlights Nasdaq listing risk due to low market value of listed securities.
My Size, Inc. approved and implemented a 1-for-8 reverse stock split of its common stock. A Certificate of Amendment was filed in Delaware, and the split became effective as of 4:30 p.m. Eastern Time on August 12, 2026. The stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on August 13, 2026, continuing under the symbol MYSZ with a new CUSIP 62844N 505.
Every eight shares of issued and outstanding common stock were automatically converted into one share, with no change to par value. Outstanding options and warrants were proportionately adjusted. No fractional shares will be issued; instead, holders receive cash based on the August 12, 2026 Nasdaq closing price, as adjusted for the split. The number of authorized shares is unchanged, while outstanding shares are reduced from approximately 4.8 million to approximately 600 thousand. The company states the split is intended to increase the per-share price to regain compliance with Nasdaq’s continued listing requirements and potentially broaden its institutional investor base.
My Size, Inc. has registered up to 3,252,404 shares of common stock for resale by Square Gate Capital Master Fund, LLC – Series 5. This includes 3,125,000 ELOC Shares, 33,654 Initial Commitment Shares and up to 93,750 True-Up Commitment Shares tied to future share prices.
These shares support a three-year $10,000,000 equity line facility under an Equity Purchase Agreement that allows, but does not obligate, My Size to sell stock to Square Gate. My Size will not receive proceeds from investors’ resale of these shares, only from any primary sales it elects to make to Square Gate.
The company highlights risks of substantial dilution, potential share price pressure from resales, strict 4.99% ownership and 19.99% exchange caps, and Nasdaq listing risks, including a low Market Value of Listed Securities. Its auditors have previously raised substantial doubt about its ability to continue as a going concern.
My Size, Inc. is registering the resale of up to 26,019,229 shares of common stock held or to be acquired by Square Gate Capital Master Fund, LLC – Series 5, all tied to an equity line of credit facility. This includes 25,000,000 ELOC Shares, 269,229 Initial Commitment Shares and up to 750,000 True-Up Commitment Shares.
The Equity Purchase Agreement lets My Size, at its discretion, sell up to $10,000,000 of stock to Square Gate over 36 months, with purchase prices set at discounts to market VWAP. My Size will not receive proceeds from investors’ resale of these shares but may receive cash when it sells ELOC Shares to Square Gate, which it plans to use for working capital and general corporate purposes.
As of August 6, 2026, My Size had 5,394,778 shares outstanding and 250,000,000 authorized, implying up to 31,144,778 shares outstanding if all registered shares are issued. The company highlights substantial potential dilution, pressure on its $0.36 share price, constraints from a 4.99% Beneficial Ownership Limitation and a 19.99% Exchange Cap. It also discloses Nasdaq listing risks, including a proposed $5.0 million Market Value of Listed Securities requirement versus its approximately $2.1 million MVLS, and geopolitical risks tied to operating from Israel.
My Size, Inc. entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, LLC - Series 5, giving it the right, but not the obligation, to sell up to $10,000,000 of common stock over a 36‑month period ending no later than August 5, 2029. Sales are initiated at the company’s discretion via regular or intraday put notices, subject to conditions and a 4.99% beneficial ownership cap.
An Exchange Cap initially limits issuance to 1,024,597 shares, or 19.99% of shares outstanding on the execution date, unless stockholders approve more or the average sale price reaches at least $0.3706. My Size paid a $100,000 commitment fee in 269,229 shares, with possible true‑up shares. Purchase prices are set at 96.5% of the lowest VWAP for regular puts or 100% of the lowest trade during intraday periods. The company agreed to standstill, variable‑rate, and competing equity line restrictions that can limit other equity financings, while the investor agreed not to short or hedge the stock. My Size will file a Form S‑1 within 30 days to register resale of the commitment shares, and any proceeds from future share sales will be used for working capital and general corporate purposes.
My Size, Inc. reported the results of its 2026 annual stockholder meeting. A quorum of 2,023,301 shares of common stock was represented. Stockholders elected Class II directors Oron Branitzky and Guy Zimmerman, each receiving more than 1.07 million votes in favor, to serve three-year terms.
Stockholders approved the advisory vote on executive compensation with 968,586 votes For. They also granted the Board discretionary authority to implement one or more Reverse Stock Splits of the common stock at ratios from 1-for-2 up to 1-for-30, which may be effected by July 21, 2027, including the treatment of fractional shares. An amendment to authorize issuance of blank check preferred stock did not receive the required majority of outstanding shares and was not approved. Stockholders ratified the appointment of Somekh Chaikin as independent public accountant with 1,901,844 votes For for the fiscal year ending December 31, 2026.
My Size, Inc. has called an annual stockholder meeting for July 21, 2026 in Tel Aviv. Stockholders will vote on electing two Class II directors, an advisory approval of 2025 executive pay, and a significant capital structure change.
The board seeks discretionary authority to implement one or more reverse stock splits of the common stock at ratios between 1‑for‑2 and up to 1‑for‑30, to be completed by July 21, 2027, primarily to help regain and maintain Nasdaq’s $1.00 minimum bid requirement. The company also asks approval to amend its charter to authorize issuance of blank check preferred stock, giving the board broad flexibility to create new preferred series. Stockholders will additionally vote on ratifying Somekh Chaikin as independent public accountant for the year ending December 31, 2026.
My Size, Inc. is soliciting proxies for its Annual Meeting of Stockholders to be held on July 21, 2026 in Tel Aviv. The board asks shareholders to vote FOR election of two Class II directors, advisory approval of executive compensation, authorization for a 1-for-2 to 1-for-30 reverse stock split, authorization to issue blank check preferred stock, and ratification of Somekh Chaikin as auditors.
The proxy statement sets the record date as May 27, 2026, states 4,818,164 shares outstanding as of that date, and discloses ownership and compensation tables, committee compositions, and equity awards. The board recommends approval of all listed proposals.